NRx Pharmaceuticals Inc.

NASDAQ: NRXP · Real-Time Price · USD
2.68
0.09 (3.47%)
At close: May 29, 2025, 3:59 PM
2.73
1.87%
After-hours: May 29, 2025, 07:57 PM EDT

NRx Pharmaceuticals Statistics

Share Statistics

NRx Pharmaceuticals has 17.29M shares outstanding. The number of shares has increased by 58.08% in one year.

Shares Outstanding 17.29M
Shares Change (YoY) 58.08%
Shares Change (QoQ) 39.87%
Owned by Institutions (%) 0.03%
Shares Floating n/a
Failed to Deliver (FTD) Shares 41,709
FTD / Avg. Volume 18.35%

Short Selling Information

The latest short interest is 1.11M, so 6.43% of the outstanding shares have been sold short.

Short Interest 1.11M
Short % of Shares Out 6.43%
Short % of Float 7.17%
Short Ratio (days to cover) 3.34

Valuation Ratios

The PE ratio is -0.92 and the forward PE ratio is 3.69. NRx Pharmaceuticals's PEG ratio is 0.02.

PE Ratio -0.92
Forward PE 3.69
PS Ratio 0
Forward PS 0
PB Ratio -1
P/FCF Ratio -2.18
PEG Ratio 0.02
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for NRx Pharmaceuticals.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.15, with a Debt / Equity ratio of -0.28.

Current Ratio 0.15
Quick Ratio 0.15
Debt / Equity -0.28
Debt / EBITDA -0.36
Debt / FCF -0.62
Interest Coverage -80.44

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee n/a
Profits Per Employee $-12,563,000
Employee Count 2
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -27.17% in the last 52 weeks. The beta is 1.45, so NRx Pharmaceuticals's price volatility has been higher than the market average.

Beta 1.45
52-Week Price Change -27.17%
50-Day Moving Average 2.12
200-Day Moving Average 2.02
Relative Strength Index (RSI) 67.02
Average Volume (20 Days) 227,318

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -18.5M
Net Income -25.13M
EBITDA -18.5M
EBIT -24.9M
Earnings Per Share (EPS) -2.39
Full Income Statement

Balance Sheet

The company has 1.44M in cash and 6.58M in debt, giving a net cash position of -5.13M.

Cash & Cash Equivalents 1.44M
Total Debt 6.58M
Net Cash -5.13M
Retained Earnings -278.27M
Total Assets 7.59M
Working Capital -25.5M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -10.64M and capital expenditures 0, giving a free cash flow of -10.64M.

Operating Cash Flow -10.64M
Capital Expenditures n/a
Free Cash Flow -10.64M
FCF Per Share -1.01
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

NRXP does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for NRXP is $31, which is 1056.7% higher than the current price. The consensus rating is "Buy".

Price Target $31
Price Target Difference 1056.7%
Analyst Consensus Buy
Analyst Count 5
Stock Forecasts

Stock Splits

The last stock split was on Apr 2, 2024. It was a backward split with a ratio of 1:10.

Last Split Date Apr 2, 2024
Split Type backward
Split Ratio 1:10

Scores

Altman Z-Score -66.04
Piotroski F-Score 4